Early-Stage Startup Valuation

This course provides the foundational skills to approach early-stage valuation systematically, helping you make informed decisions and communicate value with credibility.

What You’ll Learn:

1. Berkus Method: Understand a simple, stage-based approach for pre-revenue startups.

• Assign qualitative and quantitative values to key risk-reducing milestones, such as prototype development, management team strength, strategic partnerships, and market validation.
• Learn how this method provides a quick, structured way to value startups at very early stages without relying on financial projections.

2. Scorecard Method: Learn a market-based approach to benchmark your startup against similar ventures.

• Compare your startup to regional or sector-specific peers across factors like team, technology, market size, product stage, and traction.
• Understand how to weight and adjust valuations based on these comparisons to produce a realistic market-aligned estimate.

3. Risk Summation Method: Explore a probability-adjusted valuation approach based on key technical, regulatory, and commercial risks.

• Break down each critical risk area, assign likelihoods of success, and calculate their impact on the startup’s potential value.
• Gain insights into how early-stage risk factors can quantitatively influence valuation, helping to inform investment decisions or partnership discussions.

4. Cost Duplication Method: Learn how to estimate the value of an early-stage asset by calculating what it would cost to recreate the technology, data, and capabilities from scratch.

• Identify all the critical resources�“personnel, IP, prototypes, and operational infrastructure�“required to replicate your startup.
• Understand how this method provides a floor valuation and a practical benchmark for negotiating deals, especially when revenue or market data is limited.

Summary

By the end of this course, you will:

• Understand the strengths and limitations of multiple early-stage valuation methods.
• Be able to apply qualitative and quantitative frameworks to value pre-revenue and early-stage tech startups.
• Gain confidence in presenting defensible valuations to investors, partners, or internal stakeholders.
• Combine different methods to triangulate a realistic, evidence-based estimate of your startup’s worth.

Format: Self-paced online course

Duration: ~2 hours

Course Materials:

• Video tutorials with step-by-step valuation walkthroughs
• Templates for each valuation method (downloadable and editable Excel templates), including an example company valuation and a blank model.
• Study notes

Dr. Sophie Laurenson, PhD / Executive MBA

CEO and Founder, MedDev Central

With 20 years of experience in the medical device industry�“as a startup founder, corporate scientist, and investor, I’ve led and advised on valuations across the full product lifecycle, from early-stage concepts to due diligence and exit. My work spans financial modelling, IP strategy, corporate partnering and designing development and commercialisation plans specifically structured to maximise asset valuation.

I’ve had the privilege of working with startups, corporates, and investors to navigate the complex dynamics of the MedTech landscape, aligning innovation with market needs and long-term value creation. I’m especially passionate about building pathways for medical devices that are not only clinically and commercially viable but also socially and environmentally sustainable.

LinkedIn Profile

• Startup founders and co-founders
• CFOs, COOs, and startup operators
• Advisors, accelerators, and incubators
• Technology transfer offices (TTOs)
• Corporate intrapreneurship and open innovation/investment functions
• Early-stage investors evaluating opportunities

No legal or finance degree required�“just a desire to understand the real value of your business.

Need a custom package?

We offer tailored solutions for large teams, academic institutions, and accelerators.

Contact us to discuss enterprise licensing or co-branded delivery.

Financial support is available for female founders and those from select low and middle-income countries (LMICs).